A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials
- Laura Fertitta
- , Christina Bergqvist
- , Kavita Y. Sarin
- , Scott R. Plotkin
- , Christopher Moertel
- , Andrea K. Petersen
- , Ashley Cannon
- , Yemima Berman
- , Dominique C. Pichard
- , Class Röhl
- , Andres Lessing
- , Bernadette Brizion
- , Bastien Peiffer
- , Philippe Ravaud
- , Viet Thi Tran
- , Marie Laure Armand
- , Sabine Moryousef
- , Salah Ferkal
- , Arnaud Jannic
- , Khaled Ezzedine
*Corresponding author for this work
- Department of Dermatology
- Hôpital Henri Mondor
- INSERM U955
- Stanford University
- Massachusetts General Hospital Cancer Center
- University of Minnesota Twin Cities
- Randall Children s Hospital at Legacy Emanuel Medical Center
- University of Alabama at Birmingham
- InformedDNA, USA
- University of Sydney
- National Institutes of Arthritis
- National Institutes of Health
- NF Patients United - Global Network of NF Support Groups
- Neurofibromatosis Northeast
- Assistance publique – Hôpitaux de Paris
- Hôtel-Dieu Hospital (AP-HP)
- Institut national de la santé et de la recherche médicale
- Université Paris-Est Créteil (UPEC)
Research output: Contribution to journal › Article › peer-review